Published in Transplant Proc on June 01, 1995
Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature. Oncol Lett (2015) 0.80
Spectrum of lymphoproliferative disorders following renal transplantation in North India. Indian J Nephrol (2013) 0.80
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation. NDT Plus (2010) 0.76
Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation. Indian J Nephrol (2016) 0.75
Late onset epstein barr virus seropositive posttransplant lymphoproliferative disorder in two renal transplant receivers. Turk J Haematol (2013) 0.75
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
Value and quality of perinatal and infant postmortem examinations: cohort analysis of 400 consecutive deaths. BMJ (1995) 4.54
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Corporal punishment by American parents: national data on prevalence, chronicity, severity, and duration, in relation to child and family characteristics. Clin Child Fam Psychol Rev (1999) 3.17
Effect of changing the stillbirth definition on evaluation of perinatal mortality rates. Lancet (1995) 2.55
Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53
Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet (1971) 1.82
The bleeding disorder of uraemia. A qualitative platelet defect. Lancet (1966) 1.69
High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52
Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol (2001) 1.51
Epidemic listeriosis in the newborn. Br Med J (1971) 1.46
Physiological changes during liver transplantation. Anaesth Intensive Care (1989) 1.43
Total-body nitrogen by neutron activation in maintenance dialysis. Am J Kidney Dis (1990) 1.43
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis (2000) 1.43
Perinatal and infant postmortem examinations: how well are we doing? J Clin Pathol (1995) 1.42
Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med (1969) 1.42
Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration. J Pain Symptom Manage (1995) 1.39
Retrieval of organs for transplantation: experience of the Australian National Liver Transplantation Unit. Med J Aust (1996) 1.39
Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation (2001) 1.38
The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets. J Allergy Clin Immunol (1988) 1.38
Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab (1999) 1.33
Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J Immunother (2001) 1.31
Peritoneal and haemodialysis: a comparison of their morbidity, and of the mortality suffered by dialysed patients. Q J Med (1966) 1.28
Perinatal post-mortem radiography--experience with 2500 cases. Br J Radiol (1978) 1.25
Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control (1992) 1.22
International renal-cell-cancer study. VI. the role of medical and family history. Int J Cancer (1996) 1.22
Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med (1967) 1.21
Development and morphology of the sternal foramen. Am J Forensic Med Pathol (1988) 1.19
Cancer and survival after cadaveric donor renal transplantation. Transplant Proc (1979) 1.18
Survival of very low birthweight and very preterm infants in a geographically defined population. Acta Paediatr (1997) 1.16
Risk factors for cancer of the renal parenchyma. Int J Cancer (1988) 1.14
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis. Ann Thorac Surg (2001) 1.13
International renal-cell cancer study. II. Analgesics. Int J Cancer (1995) 1.12
Cancer incidence among semiconductor and electronic storage device workers. Occup Environ Med (2006) 1.10
Hyperparathyroidism after renal transplantation. Br Med J (1975) 1.10
Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc (1977) 1.09
Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation (1966) 1.07
Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage. Kidney Int (1984) 1.07
Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl (1993) 1.06
Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol (1983) 1.05
Cancer following successful cadaveric donor renal transplantation. Transplant Proc (1981) 1.05
Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail. Lancet (1973) 1.04
Improving the quality of perinatal and infant necropsy examinations: a follow up study. J Clin Pathol (1998) 1.03
Reversal of renal failure by revascularisation of kidneys with thrombosed renal arteries. Lancet (1973) 1.03
The Health Status Questionnaire: achieving concordance with published disability criteria. Arch Dis Child (2002) 1.02
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Relevance of salt, water, and renin to hypertension in chronic renal failure. Br Med J (1970) 1.01
Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant (2006) 1.01
Deaths from occlusive arterial disease in renal allograft recipients. Br Med J (1974) 1.01
Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. Am Rev Respir Dis (1987) 1.00
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
A controlled clinical trial of machine perfusion of cadaveric donor renal allografts. Lancet (1975) 0.98
Aortic occlusion and vascular isolation allowing avascular hepatic resection. Arch Surg (1990) 0.98
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
Bone loss after liver transplantation. Hepatology (1991) 0.97
Analgesic abuse and kidney disease. Aust N Z J Med (1976) 0.97
Renal autotransplantation for severe loin-pain/haematuria syndrome. Lancet (1985) 0.95
Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation. Br J Dermatol (1987) 0.95
Risk factors for kidney cancer in New South Wales. IV. Occupation. Br J Ind Med (1993) 0.94
Analgesics and cancer of the renal pelvis in New South Wales. Cancer (1982) 0.94
Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer (1993) 0.93
Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol (1992) 0.93
Effects of ultraviolet radiation and immunosuppressive therapy on mouse epidermal cell kinetics. Br J Dermatol (1986) 0.92
Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Chest (1992) 0.92
Obstruction of the upper airway as a mechanism of sudden infant death: evidence for a restricted nasal airway contributing to pharyngeal obstruction. Sleep (1980) 0.91
The living, related kidney donor: a follow-up study. Med J Aust (1988) 0.91
Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol (1996) 0.91
Comprehensive one-day renal function testing in man. J Clin Pathol (1974) 0.91
Anomalies of the human chest plate area. Radiographic findings in a large autopsy population. Am J Forensic Med Pathol (1988) 0.90
Quantitative skeletal histology in untreated end-stage renal failure. Br Med J (1973) 0.90
High-density lipoprotein in chronic renal failure and after renal transplantation. Br Med J (1979) 0.90
Bilateral nephrectomy for malignant hypertension. Lancet (1972) 0.90
Immunoglobulin abnormalities in renal transplant recipients. Transplantation (1989) 0.90
Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. Am J Med (1985) 0.90
The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol (1994) 0.90
Primary graft dysfunction after liver transplantation. Transplant Proc (2000) 0.88
Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation (1998) 0.88
Cancer in patients treated with immunosuppressive drugs. Br Med J (Clin Res Ed) (1981) 0.88
Giant cavernous haemangioma: a rare indication for liver transplantation. Aust N Z J Surg (1996) 0.88
Hyperlipidemia in renal transplant recipients: natural history and response to treatment. Medicine (Baltimore) (1994) 0.87
Hepatic resection with vascular isolation and routine supraceliac aortic clamping. Am J Surg (1996) 0.87
Embolic and ischemic complications after anastomosis of radial artery to cephalic vein. Surgery (1969) 0.87
Cryopreserved porcine hepatocytes in a liver biodialysis system. Transplant Proc (2001) 0.87
Trimethoprim/sulfamethoxazole and renal function in transplant patients. Clin Pharmacol Ther (1978) 0.87
Perinatal infections by group B beta-haemolytic streptococci. Br J Obstet Gynaecol (1976) 0.87
Peritoneal dialysis using a semi-permanent intraabdominal catheter. Med J Aust (1973) 0.86